A carregar...

PHARMACOECONOMIC ASPECT OF OMALIZUMAB APPLICATION AMONG THE PATIENTS, SUFFERING FROM THE BRONCHIAL ASTHMA

In the given article, the authors discuss the most difficult issue of the pediatrics, which is the treatment of the severe bronchial asthma. Our columnist is professor A.S. Kolbin introduces omalizumab, a new medication from the monoclonal antibodies group, to our readers. It allows practitioners to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A.S. Kolbin, N.N. Klimko, B.V. Andreev
Formato: Artigo
Idioma:Inglês
Publicado em: Paediatrician Publishers, LLC 2008-07-01
Colecção:Pediatričeskaâ Farmakologiâ
Acesso em linha:https://www.pedpharma.ru/jour/article/view/832
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!